Financial Performance - In Q1 2025, the company achieved operating revenue of CNY 44.50 billion, a decrease of 0.98% compared to the same period last year[10]. - The net profit attributable to shareholders was CNY 1.44 billion, representing an increase of 18.77% year-on-year[10]. - The net profit after deducting non-recurring gains and losses was CNY 1.41 billion, up 22.63% from the previous year[10]. - The basic earnings per share increased by 20.00% to CNY 0.24 compared to CNY 0.20 in the same period last year[4]. - The company reported a net profit of CNY 1.60 billion for Q1 2025, up from CNY 1.35 billion in Q1 2024, indicating a growth of 18.52%[16]. - The net profit for Q1 2025 was approximately ¥1.60 billion, an increase from ¥1.35 billion in Q1 2024, representing a growth of about 18.2%[17]. - The net profit attributable to shareholders of the parent company was approximately ¥1.44 billion, up from ¥1.22 billion in the same period last year, reflecting a growth of around 18.7%[17]. - The total comprehensive income for Q1 2025 was approximately ¥1.59 billion, compared to ¥1.35 billion in Q1 2024, indicating an increase of about 18.1%[17]. - The basic and diluted earnings per share for Q1 2025 were both ¥0.24, compared to ¥0.20 in Q1 2024, marking a 20% increase[17]. Assets and Liabilities - The company's total assets at the end of the reporting period were CNY 230.98 billion, a decrease of 1.05% from the end of the previous year[5]. - Total assets as of March 31, 2025, amounted to CNY 230.98 billion, a decrease from CNY 233.42 billion as of December 31, 2024[14]. - Current assets totaled CNY 171.98 billion, down from CNY 175.16 billion in the previous period[12]. - Total liabilities as of March 31, 2025, were CNY 160.38 billion, down from CNY 164.52 billion at the end of 2024[14]. - Long-term borrowings increased to CNY 7.30 billion from CNY 5.31 billion, reflecting a growth of 37.06%[14]. - Shareholders' equity attributable to shareholders increased by 2.48% to CNY 63.82 billion compared to the previous year[5]. - The total equity attributable to shareholders increased to CNY 63.82 billion from CNY 62.28 billion, a rise of 2.47%[14]. Cash Flow - The net cash flow from operating activities was negative at CNY -15.10 billion, compared to CNY -6.77 billion in the same period last year[4]. - Cash flow from operating activities showed a net outflow of approximately ¥15.10 billion in Q1 2025, worsening from a net outflow of ¥6.77 billion in Q1 2024[21]. - Cash flow from investing activities resulted in a net outflow of approximately ¥899.26 million in Q1 2025, compared to a net inflow of ¥603.33 million in Q1 2024[22]. - Cash flow from financing activities generated a net inflow of approximately ¥654.94 million in Q1 2025, contrasting with a net outflow of ¥1.25 billion in Q1 2024[22]. - The total cash and cash equivalents at the end of Q1 2025 were approximately ¥27.28 billion, down from ¥35.59 billion at the end of Q1 2024[22]. - Cash and cash equivalents decreased to CNY 33.33 billion from CNY 50.07 billion, representing a decline of 33.33%[12]. Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 105,401[8]. Research and Development - Research and development expenses for Q1 2025 were CNY 1.16 billion, an increase of 21% compared to CNY 959.46 million in Q1 2024[16]. Strategic Outlook - The company emphasized its commitment to innovation-driven development and high-quality growth in its strategic outlook[10]. Sales Performance - The company reported a decrease in cash received from sales of goods and services, totaling approximately ¥40.02 billion in Q1 2025, down from ¥47.66 billion in Q1 2024, a decline of about 16.4%[21]. - The company experienced a net increase in customer deposits and interbank deposits of approximately -¥1.57 billion in Q1 2025, compared to -¥1.67 billion in Q1 2024[21].
中国化学(601117) - 2025 Q1 - 季度财报